Apr 26 |
With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
|
Apr 18 |
Codexis to Report First Quarter 2024 Financial Results on May 2
|
Apr 11 |
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
|
Mar 30 |
Favourable Signals For Codexis: Numerous Insiders Acquired Stock
|
Mar 1 |
Benchmark raises Codexis to buy; cites Q4 earnings, guidance
|
Feb 27 |
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Feb 26 |
Codexis stock climbs 11% on Roche licensing deal for DNA ligases
|
Feb 26 |
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
|
Feb 26 |
Codexis to Participate in TD Cowen 44th Annual Health Care Conference
|
Feb 20 |
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
|